All Clinical Trials

A listing of 23128 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Study

Recruiting

Are you tired of living with chronic cough? The ASPIRE Study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough. You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you.

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Allergic Asthma

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Trial

Crohn's Disease Clinical Study

Recruiting

Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.

Conditions:

Crohn's Disease

Crohn Disease

Crohns Disease

Crohn's Disease (CD)

Crohn Colitis

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512

Recruiting

The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: Local Institution, Birmingham, Alabama +197 locations

Local Institution, Birmingham, Alabama

Local Institution - 0021, Birmingham, Alabama

Local Institution - 0013, Muscle Shoals, Alabama

Local Institute, Goodyear, Arizona

Local Institution - 0023, Anaheim, California

Local Institution, Anaheim, California

Local Institution - 0045, Burbank, California

Local Institution, Corona, California

Local Institution - 0048, Downey, California

Local Institution - 0052, Fountain Valley, California

Local Institute, Los Angeles, California

Local Institute, Santa Rosa, California

Local Institution - 0051, Santa Rosa, California

Local Institution - 0057, Washington, District of Columbia

Florida Cancer Specialists & Research Institute, Brooksville, Florida

Local Institution, Brooksville, Florida

Local Institution - 0044, Fort Lauderdale, Florida

Local Institution - 0017, Jacksonville, Florida

Local Institution, Jacksonville, Florida

Local Institution - 0046, Savannah, Georgia

Local Institute, Valdosta, Georgia

Local Institution - 0047, Valdosta, Georgia

Local Institution, Skokie, Illinois

Local Institution - 0041, Springfield, Illinois

Local Institution - 0012, Urbana, Illinois

Local Institution - 0058, Anderson, Indiana

Local Institution - 0011, Indianapolis, Indiana

Local Institution, Indianapolis, Indiana

Local Institution - 0061, Des Moines, Iowa

Local Institute, Sioux City, Iowa

Local Institution - 0018, Sioux City, Iowa

Local Institution - 0062, Lexington, Kentucky

Local Institution - 0064, London, Kentucky

Local Institute, Louisville, Kentucky

Local Institution - 0042, Louisville, Kentucky

Cancer Center of Acadiana at Lafayette General Health, Lafayette, Louisiana

Local Institution, Lafayette, Louisiana

Local Institution - 0009, Shreveport, Louisiana

Local Institution, Shreveport, Louisiana

Local Institution, Minneapolis, Minnesota

Local Institution - 0030, Woodbury, Minnesota

Local Institution - 0059, Jackson, Mississippi

Local Institute, Southaven, Mississippi

Local Institute, Kansas City, Missouri

Local Institution - 0050, Kansas City, Missouri

Local Institution - 0037, Missoula, Missouri

Local Institute, Saint Joseph, Missouri

Local Institution - 0015, Saint Louis, Missouri

Local Institution, Saint Louis, Missouri

Local Institution - 0020, Springfield, Missouri

Local Institution, Springfield, Missouri

Local Institute, Missoula, Montana

Local Institution - 0060, Lincoln, Nebraska

Local Institute, Omaha, Nebraska

Local Institution - 0024, Omaha, Nebraska

Local Institution - 008, Does Not Exist, New Jersey

Generic Country - Canada, No City Provided, New Jersey

Generic Country - France, No City Provided, New Jersey

Generic Country - Germany, No City Provided, New Jersey

Generic Country - Italy, No City Provided, New Jersey

Generic Country - UK, No City Provided, New Jersey

Generic Country - USA, No City Provided, New Jersey

Local Institution - 0049, Stony Brook, New York

Local Institute, Cary, North Carolina

Local Institution - 0033, Cary, North Carolina

Local Institution - 0010, Gastonia, North Carolina

Local Institution, Gastonia, North Carolina

Local Institute, Canton, Ohio

Local Institution - 0022, Canton, Ohio

Local Institute, Cleveland, Ohio

Local Institution - 0019, Cleveland, Ohio

Local Institute, Tulsa, Oklahoma

Tulsa Cancer Institute PLLC, Tulsa, Oklahoma

Local Institute, Portland, Oregon

Local Institute, Pottstown, Pennsylvania

Local Institution - 0043, Pottstown, Pennsylvania

Local Institute, Charleston, South Carolina

Local Institution - 0016, Charleston, South Carolina

Local Institute, Knoxville, Tennessee

Local Institution - 0038, Knoxville, Tennessee

Local Institution - 0035, Memphis, Tennessee

Local Institution, Memphis, Tennessee

Local Institute, Amarillo, Texas

Local Institution - 0029, Amarillo, Texas

Local Institution - 0063, Bryan, Texas

Local Institute, Corpus Christi, Texas

Local Institute, Dallas, Texas

Local Institution - 0025, Dallas, Texas

Local Institute, Dallas, Texas

Local Institution - 0014, Dallas, Texas

Local Institution - 0032, Garland, Texas

Local Institute, San Antonio, Texas

Local Institution - 0027, San Antonio, Texas

Local Institute, Sherman, Texas

Local Institution - 0028, Sherman, Texas

Local Institute, Seattle, Washington

Local Institution - 0039, Seattle, Washington

Local Institute, Spokane, Washington

Local Institution - 0026, Spokane, Washington

Local Institute, Yakima, Washington

Local Institution - 0031, Yakima, Washington

Local Institution - 0065, Toronto, Ontario

Local Institute, Toronto, Ontario

Local Institution - 0066, Toronto, Ontario

Local Institute, Weston, Ontario

Local Institute, Blois, Not set

Local Institution - 0106, Cannes Cedex, Not set

Local Institution - 0099, Chalon sur Saone, Not set

Local Institute, Chalon sur Saone, Not set

Local Institute, La Roche sur Yon, Not set

Local Institution - 0100, La Roche-sur-yon Cedex 9, Not set

Local Institution - 0104, Limoges, Not set

Local Institute, Limoges, Not set

Local Institution - 0105, Meaux, Not set

Local Institute, Meaux, Not set

Local Institution - 0102, Nantes, Not set

Local Institute, Nantes, Not set

Local Institution - 0101, Perigueux, Not set

Local Institute, Rennes, Not set

Local Institution - 0103, Rennes, Not set

Local Institute, Heidelberg, Baden-Württemberg

Local Institute, Hamm, Nordrhein-Westfalen

Local Institute, Aschaffenburg, Not set

Local Institution - 0072, Aschaffenburg, Not set

Local Institute, Berlin, Not set

Local Institution - 0068, Berlin, Not set

Local Institution - 0081, Bielefeld, Not set

Local Institution, Bochum, Not set

Local Institute, Dresden, Not set

Local Institution - 0069, Dresden, Not set

Local Institution - 0082, Dresden, Not set

Local Institution - 0077, Frankfurt-oder, Not set

Local Institution - 0084, Gelsenkirchen, Not set

Local Institution - 0089, Goslar, Not set

Local Institution - 0070, Hamm, Not set

Local Institution - 0071, Heidelberg, Not set

Local Institution - 0088, Kiel, Not set

Local Institution - 0087, Köln, Not set

Local Institution - 0076, Ludwigsburg, Not set

Local Institute, Magdeburg, Not set

Local Institution - 0067, Magdeburg, Not set

Local Institution - 0073, Muenchen, Not set

Local Institution - 0079, Mutlangen, Not set

Local Institute, München, Not set

Local Institution - 0080, Oldenburg, Not set

Local Institution - 0075, Reutlingen, Not set

Local Institution - 0074, Rostock, Not set

Local Institution - 0086, Rostock, Not set

Local Institute, Rostock, Not set

Local Institution - 0078, Traunstein, Not set

Local Institution - 0085, Wiesbaden, Not set

Local Institute, Pesaro, Pesaro E Urbino

Local Institute, Ancona, Not set

Local Institution - 0108, Ancona, Not set

Local Institute, Ancona, Not set

Local Institution - 0119, Cagliari, Not set

Local Institute, Cagliari, Not set

Local Institution - 0111, Firenze, Not set

Local Institute, Firenze, Not set

Local Institute, Lecce, Not set

Local Institution - 0113, Lecce, Not set

Local Institution - 0124, Messina, Not set

Local Institution - 0120, Messina, Not set

Local Institute, Milano, Not set

Local Institution - 0116, Milano, Not set

Local Institute, Napoli, Not set

Local Institution - 0114, Napoli, Not set

Local Institution - 0115, Pesaro, Not set

Local Institution - 0121, Pescara, Not set

Local Institute, Roma, Not set

Local Institution - 0109, Roma, Not set

Local Institution - 0110, Roma, Not set

Local Institution - 0118, Roma, Not set

Local Institution, Roma, Not set

Local Institution - 0122, San Giovanni Rotondo (FG), Not set

Local Institution - 0107, Terni, Not set

Local Institute, Terni, Not set

Local Institute, Torino, Not set

Local Institution - 0112, Torino, Not set

Local Institute, Vicenza, Not set

Local Institution - 0117, Vicenza, Not set

Local Institute, Truro, Cornwall

Local Institution - 0098, Harrow, Greater London

Local Institute, Leeds, Not set

Local Institution - 0092, Leeds, Not set

Local Institution - 0091, Liverpool, Not set

Local Institution, Liverpool, Not set

Local Institution - 0097, Manchester, Not set

Local Institute, Nottingham, Not set

Local Institution - 0095, Nottingham, Not set

Local Institute, Stafford, Not set

Local Institution - 0096, Stafford, Not set

Local Institute, Swansea, Not set

Local Institution - 0093, Swansea, Not set

Local Institution - 0094, Truro, Not set

Conditions: Multiple Myeloma

Learn More ›

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients with Operative Metastatic Brain Tumors

NCT03750227

Recruiting

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by surgery. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: Mayo Clinic in Arizona, Scottsdale, Arizona +3 locations

Conditions: Metastatic Malignant Neoplasm in the Brain, Malignant Solid Neoplasm

Learn More ›

A Study of DF6002 Alone and in Combination With Nivolumab

NCT04423029

Recruiting

The purpose of this study is to evaluate the safety, tolerability, drug-levels, drug-effects and preliminary anti-tumor activity of DF6002 alone and in combination with Nivolumab in participants with advanced solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: University of California Irvine, Orange, California +32 locations

University of California Irvine, Orange, California

SCRI - HealthOne Denver, Denver, Colorado

Yale School of Medicine, New Haven, Connecticut

University of Miami, Miami, Florida

Augusta University Georgia Cancer Center, Augusta, Georgia

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Local Institution, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

HealthPartners Cancer Center at Regions Hospital, Saint Paul, Minnesota

Atlantic Health System, Morristown, New Jersey

Montefiore Medical Center, Bronx, New York

Roswell Park Comprehensive Cancer Center, Buffalo, New York

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Stephenson Cancer Center, Oklahoma City, Oklahoma

Rhode Island Hospital, Providence, Rhode Island

SCRI - Tennessee Oncology - Saint Thomas West Clinic, Nashville, Tennessee

University of Texas MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute and Hospital, Salt Lake City, Utah

USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax, Virginia

Froedtert Hospital, Milwaukee, Wisconsin

Local Institution - 0023, Box Hill, Not set

Local Institution - 0022, Heidelberg, Not set

Institut Bergonié, Bordeaux Cedex, Not set

Hôpital Saint-Louis, Paris, Not set

Centre Hospitalier Lyon-Sud, Pierre-Benite, Not set

Gustave Roussy, Villejuif, Not set

Hospital Universitari Vall d'Hebrón, Barcelona, Not set

Clinica Universidad de Navarra - Madrid, Madrid, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid, Not set

Clinica Universidad de Navarra - Pamplona, Pamplona, Not set

Conditions: Solid Tumors

Learn More ›

Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases

NCT05026983

Recruiting

This phase II trial studies the effects of binimetinib and encorafenib in treating patients with melanoma that has spread to the central nervous system (metastases). Binimetinib and encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving binimetinib and encorafenib may help control melanoma that has spread to the brain.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8

Learn More ›

Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health

NCT05553743

Recruiting

The purpose of the UCSD Human Milk Biorepository is to establish and maintain a repository of breast milk samples that can be used to learn more about how breast milk influences infant and child health.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: University of California, San Diego, San Diego, California

Conditions: Breastfeeding, COVID-19 Infection, COVID-19 Vaccine, Remdesivir, Antibiotics

Learn More ›

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

NCT05710328

Recruiting

This phase II trial tests how well an imaging procedure called fludeoxyglucose F-18 (FDG) positron emission tomography/computed tomography (PET/CT) works in predicting response to standard of care chemotherapy prior to surgery in patients with HER2-positive stage IIa-IIIc breast cancer. FDG is a radioactive tracer that is given in a vein before PET/CT imaging and helps to identify areas of active cancer. PET and CT are imaging techniques that make detailed, computerized pictures of areas inside... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +101 locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Cancer Center at Saint Joseph's, Phoenix, Arizona

Los Angeles General Medical Center, Los Angeles, California

USC / Norris Comprehensive Cancer Center, Los Angeles, California

Saint John's Cancer Institute, Santa Monica, California

Sibley Memorial Hospital, Washington, District of Columbia

Mayo Clinic in Florida, Jacksonville, Florida

Hawaii Cancer Care - Westridge, 'Aiea, Hawaii

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii

Queen's Cancer Cenrer - POB I, Honolulu, Hawaii

Queen's Medical Center, Honolulu, Hawaii

University of Hawaii Cancer Center, Honolulu, Hawaii

Queen's Cancer Center - Kuakini, Honolulu, Hawaii

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Castle Medical Center, Kailua, Hawaii

Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii

Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho

Northwestern University, Chicago, Illinois

Carle at The Riverfront, Danville, Illinois

Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois

Carle Physician Group-Effingham, Effingham, Illinois

Northwestern Medicine Cancer Center Delnor, Geneva, Illinois

Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Carle Cancer Center, Urbana, Illinois

Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois

The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky

Louisiana State University Health Science Center, New Orleans, Louisiana

University Medical Center New Orleans, New Orleans, Louisiana

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Minnesota Oncology - Burnsville, Burnsville, Minnesota

Mercy Hospital, Coon Rapids, Minnesota

Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota

Abbott-Northwestern Hospital, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

United Hospital, Saint Paul, Minnesota

Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota

Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi

Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi

Mercy Hospital South, Saint Louis, Missouri

CoxHealth South Hospital, Springfield, Missouri

Nebraska Medicine-Bellevue, Bellevue, Nebraska

Nebraska Medicine-Village Pointe, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Cooper Hospital University Medical Center, Camden, New Jersey

Morristown Medical Center, Morristown, New Jersey

Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

Inspira Medical Center Vineland, Vineland, New Jersey

MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey

Montefiore Medical Center-Einstein Campus, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Indu and Raj Soin Medical Center, Beavercreek, Ohio

MetroHealth Medical Center, Cleveland, Ohio

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Kettering Medical Center, Kettering, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Bryn Mawr Hospital, Bryn Mawr, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Riddle Memorial Hospital, Media, Pennsylvania

Bryn Mawr Health Center, Newtown Square, Pennsylvania

Paoli Memorial Hospital, Paoli, Pennsylvania

Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania

Community Medical Center, Scranton, Pennsylvania

Chester County Hospital, West Chester, Pennsylvania

Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania

Lankenau Medical Center, Wynnewood, Pennsylvania

Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee

Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee

Dell Seton Medical Center at The University of Texas, Austin, Texas

University of Texas at Austin, Austin, Texas

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

FHCC South Lake Union, Seattle, Washington

Fred Hutchinson Cancer Center, Seattle, Washington

University of Washington Medical Center - Montlake, Seattle, Washington

Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin

Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin

Aurora Health Care Germantown Health Center, Germantown, Wisconsin

Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin

Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin

Marshfield Medical Center - Ladysmith, Ladysmith, Wisconsin

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin

Aurora Sinai Medical Center, Milwaukee, Wisconsin

Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin

Marshfield Medical Center - Neillsville, Neillsville, Wisconsin

Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin

Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin

Aurora West Allis Medical Center, West Allis, Wisconsin

Marshfield Medical Center - Weston, Weston, Wisconsin

Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin

Cancer Center-Metro Medical Center Bayamon, Bayamon, Not set

Doctors Cancer Center, Manati, Not set

San Juan Community Oncology Group, San Juan, Not set

Centro Comprensivo de Cancer de UPR, San Juan, Not set

San Juan City Hospital, San Juan, Not set

Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma

Learn More ›

Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

NCT05868421

Recruiting

This study is recruiting Veterans who currently smoke cigarettes and support persons who are nominated by the Veterans. The purpose of this study is to assist Veterans with smoking cessation by asking Veterans to choose a support person who will assist them with the quitting process, or who may assist them with the quitting process once the Veteran is ready to quit smoking sometime in the future. Study staff will assess how much or how little social support during the Veteran's quitting process... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota

Conditions: Smoking Cessation, Veterans Health

Learn More ›

EMBRACE: Exercising Together

NCT06049355

Recruiting

This phase II trial tests how well an exercise intervention, Exercising Together, works in preventing declines in physical and mental health in couples during radiation treatment for cancer. Treatments for cancer can cause side effects such as fatigue as well as strain on relationships. Exercising Together is a partnered exercise program that adds communication, collaboration and support between partners during exercise to fortify the relationship and amplify the benefits of physical training. E... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: OHSU Knight Cancer Institute, Portland, Oregon

Conditions: Breast Carcinoma, Prostate Carcinoma

Learn More ›

SARC044: a Phase II Trial of Bezuclastinib in Combination with Sunitinib in Patients with GIST

NCT06208748

Recruiting

This is an open label, single arm, phase 2 trial investigating bezuclastinib plus sunitinib in patients with GIST who have previously progressed on sunitinib.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida +3 locations

Conditions: Gastrointestinal Stromal Tumors, GIST

Learn More ›

Hypofractionated WPPT With HDR Boost

NCT06591819

Recruiting

This is a phase II study of ultrahypofractionated whole pelvis proton therapy with brachytherapy boost for patients with high risk or unfavorable intermediate risk prostate with elevated risk of lymph node involvement.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: University of Pennsylvania, Philadelphia, Pennsylvania

Conditions: Prostate Cancer

Learn More ›

Mindfulness and Placebo for Pain (MAPP) Study

NCT06720909

Recruiting

This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up. Participants will be randomly assigned to one of the following three conditions: 1. Mindfulness-Based Stress Reduction (MBSR) 2... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/28/2025

Locations: Arizona State University Downtown Phoenix Campus, Phoenix, Arizona +1 locations

Conditions: Chronic Pain

Learn More ›

Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge

NCT06805487

Recruiting

Zika virus (ZIKV) is an illness people can get from mosquitoes. The infection is generally mild with symptoms that include a fever, rash, red eyes, and joint pain, though most of those infected have no symptoms. Preventing ZIKV is important because if a pregnant person is infected with ZIKV, it can cause birth defects in their unborn child. The goals of this study are to find out if people who have already been infected with one type of ZIKV can get infected with ZIKV a second time, and to test... Read More

Gender:

ALL

Ages:

Between 18 years and 40 years

Trial Updated:

01/28/2025

Locations: Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland +1 locations

Conditions: Zika Virus

Learn More ›